Drug intelligence / Profile preview

DWC202405 + DWC202313

Development stage
Unknown
Lead developer
Daewoong Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

**DWC202405 + DWC202313** is an investigational **combination drug therapy** currently in phase III clinical trials for the treatment of **essential hypertension**. This combination is being studied specifically for patients whose hypertension is inadequately controlled with DWC202405 alone. The precise pharmacologic classes, individual generic names, and mechanisms of DWC202405 and DWC202313 are not provided in public sources; both are code-named investigational agents from Daewoong Pharmaceutical. The combination is evaluated in randomized, double-blind clinical trials as part of a strategy to improve blood pressure control in this patient population[1][2][3].

Brand names
DWC202405 + DWC202313
Other names
DWC202405 + DWC202313
02

Targets

CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on DWC202405 + DWC202313.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DWC202405 + DWC202313.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call